| Code | 93105 | ||||||||||
| MA number | 20/0162/87-CS | ||||||||||
| Product Form: | sol inj 50x2 ml/10 mg | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 20 - ANTIEMETICA, ANTIVERTIGINOSA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Container: | glass ampoule | ||||||||||
| Route of admin.: | Intramuscular or intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 24.06.1987 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| SPC: |
SPC_DEGAN 10 mg_2 ml_sol inj_11_2019.doc
|
| PIL: |
PIL_DEGAN 10 mg_2 ml_sol inj_11_2024.pdf
|
| Safety feature | Yes |
| Data update: | 17.04.2018 |
